Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model.

Megiddo I, Colson A, Chisholm D, Dua T, Nandi A, Laxminarayan R. Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model. Epilepsia. 2016;57(3):464-74. DOI: 10.1111/epi.13294. PubMed PMID: 26765291.

PCDH19-related epilepsy in two mosaic male patients.

Terracciano A, Trivisano M, Cusmai R, De Palma L, Fusco L, Compagnucci C, et al. PCDH19-related epilepsy in two mosaic male patients. Epilepsia. 2016;57(3):e51-5. DOI: 10.1111/epi.13295. PubMed PMID: 26765483.

Measurement equivalence of the newly developed Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55).

Ferro MA, Goodwin SW, Sabaz M, Speechley KN. Measurement equivalence of the newly developed Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55). Epilepsia. 2016;57(3):427-35. DOI: 10.1111/epi.13296. PubMed PMID: 26752612.

Reproductive disorders in patients with epilepsy; we need high-quality studies.

Asadi-Pooya AA. Reproductive disorders in patients with epilepsy; we need high-quality studies. Epilepsia. 2016;57(1):165-6. DOI: 10.1111/epi.13260. PubMed PMID: 26748897.

In Memoriam: Hanneke De Boer (1946-2015).

Reynolds ET, Covanis A, Perucca E. In Memoriam: Hanneke De Boer (1946-2015). Epilepsia. 2016;57(1):162-3. DOI: 10.1111/epi.13293. PubMed PMID: 26748896.

The relevance of "diagnostic delay" in epilepsy.

Gasparini S, Ferlazzo E, Sueri C, Aguglia U. The relevance of "diagnostic delay" in epilepsy. Epilepsia. 2016;57(1):165. DOI: 10.1111/epi.13237. PubMed PMID: 26748898.

Introduction-Epilepsy Research UK expert workshop 2014: SUDEP: Time for prevention-evidence and clinical translation Proceedings from the Epilepsy Research UK 2014 Expert Workshop.

Nashef L, Richardson MP. Introduction-Epilepsy Research UK expert workshop 2014: SUDEP: Time for prevention-evidence and clinical translation Proceedings from the Epilepsy Research UK 2014 Expert Workshop. Epilepsia. 2016;57 Suppl 1:1-3. DOI: 10.1111/epi.13238. PubMed PMID: 26749011.

Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs.

Tomson T, Surges R, Delamont R, Haywood S, Hesdorffer DC. Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs. Epilepsia. 2016;57 Suppl 1:4-16. DOI: 10.1111/epi.13234. PubMed PMID: 26749012.

Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention.

Goldman AM, Behr ER, Semsarian C, Bagnall RD, Sisodiya S, Cooper PN. Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention. Epilepsia. 2016;57 Suppl 1:17-25. DOI: 10.1111/epi.13232. PubMed PMID: 26749013.

From unwitnessed fatality to witnessed rescue: Nonpharmacologic interventions in sudden unexpected death in epilepsy.

Rugg-Gunn F, Duncan J, Hjalgrim H, Seyal M, Bateman L. From unwitnessed fatality to witnessed rescue: Nonpharmacologic interventions in sudden unexpected death in epilepsy. Epilepsia. 2016;57 Suppl 1:26-34. DOI: 10.1111/epi.13231. PubMed PMID: 26749014.